Results 151 to 160 of about 9,765 (234)

Hepatitis C: current treatments, emerging therapies and tackling health inequities on the path to global elimination. [PDF]

Clin Med (Lond)
Farooq HZ, Foster GR.
europepmc   +1 more source

Hepatitis C Direct-Acting Antivirals in the Immunosuppressed Host: Mechanisms, Interactions, and Clinical Outcomes. [PDF]

Viruses
AlKaabi H, AlSinani S, El-Kassas M, Alswat KA, AlNaamani KM.   +4 more
europepmc   +1 more source

Hepatitis C virus NS3/4A protease cleaves SPG20, a key regulator of lipid droplet turnover, to promote lipid droplet formation. [PDF]

J Virol
Matsui C, Yuliandari P, Deng L, Abe T, Shoji I.   +4 more
europepmc   +1 more source

Linezolid for multidrug-resistant tuberculosis. [PDF]

, 2013
Cox, H, Ford, N, Goemaere, E, Hughes, J
core   +2 more sources

Mechanistic and Kinetic Insights into the Acylation Reaction of Hepatitis C Virus NS3/NS4A Serine Protease with NS4B/5A Substrate. [PDF]

Biomolecules
Martínez-González JÁ, Salazar-Sanchez N, Larriva-Hormigos M, Martínez R, González M.   +4 more
europepmc   +1 more source

Deep Sequencing Analysis of Hepatitis C Virus Subtypes and Resistance-Associated Substitutions in Genotype 4 Patients Resistant to Direct-Acting Antiviral (DAA) Treatment in Egypt. [PDF]

Int J Mol Sci
Garcia-Cehic D, Mosbeh A, A Gad H, Gomaa AI, Ibañez Lligoña M, Gregori J, Colomer-Castell S, Campos C, Rodriguez-Frias F, Esteban JI, Kohla MS, Abdel-Rahman MH, Quer J.   +12 more
europepmc   +1 more source

Resistance studies of a dithiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems. [PDF]

Antimicrob Agents Chemother, 2013
Lin HM, Wang JC, Hu HS, Wu PS, Wang WH, Wu SY, Yang CC, Yeh TK, Hsu TA, Jiaang WT, Chao YS, Chern JH, Yueh A.   +12 more
europepmc   +1 more source

Genetic Characterization of Hepatitis C Virus Among People Who Use Crack Cocaine: A Study Conducted on the Brazilian Amazon Coast. [PDF]

Pathogens
Heymbeeck JAA, do Nascimento WL, Freitas MCS, de Sousa Rocha L, Costa FF, de Queiroz JPQ, Simeone D, Martins LC, Machado LFA, Fischer B, Kupek E, Oliveira-Filho AB.   +11 more
europepmc   +1 more source

A Quinoline Derivative HZ-6d Induces Antiviral Activity Against Hepatitis C Virus Via Apoptosis-Mediated Cytotoxicity. [PDF]

Kobe J Med Sci
Suwardana GNR, Rhamadianti AF, Abe T, Deng L, Matsui C, Yasui M, Takeda N, Yamada T, Ueda M, Shoji I.   +9 more
europepmc   +1 more source

The combination of alisporivir plus an NS5A inhibitor provides additive to synergistic anti-hepatitis C virus activity without detectable cross-resistance. [PDF]

Antimicrob Agents Chemother, 2014
Chatterji U, Garcia-Rivera JA, Baugh J, Gawlik K, Wong KA, Zhong W, Brass CA, Naoumov NV, Gallay PA.   +8 more
europepmc   +1 more source